An Intermediate Alemtuzumab Schedule Reduces the Incidence of Mixed Chimerism Following Reduced-Intensity Conditioning Hematopoietic Cell Transplantation for Hemophagocytic Lymphohistiocytosis

Bibliographic Details
Title: An Intermediate Alemtuzumab Schedule Reduces the Incidence of Mixed Chimerism Following Reduced-Intensity Conditioning Hematopoietic Cell Transplantation for Hemophagocytic Lymphohistiocytosis
Authors: Marsh, Rebecca A., Kim, Mi-Ok, Liu, Chunyan, Bellman, Denise, Hart, Laura, Grimley, Michael, Kumar, Ashish, Jodele, Sonata, Myers, Kasiani C., Chandra, Sharat, Leemhuis, Tom, Mehta, Parinda A., Bleesing, Jack J., Davies, Stella M., Jordan, Michael B., Filipovich, Alexandra H.
Source: In Biology of Blood and Marrow Transplantation November 2013 19(11):1625-1631
Database: ScienceDirect
More Details
ISSN:10838791
DOI:10.1016/j.bbmt.2013.09.001
Published in:Biology of Blood and Marrow Transplantation
Language:English